Kwality Pharmaceuticals Ltd Share Price & Stock Analysis

Kwality Pharmaceuticals Ltd (BSE: 539997) is an Amritsar, Punjab-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹4,091 Cr, it ranks #926 by market cap among the 6,197 Indian listed companies on FinBizNet, and #31 of 86 in Medicinal Chemicals and Botanical Products. At ₹3,842.20 (as of 16 Nov 2026), the share price is 8.8% below its 52-week high of ₹4,211.00 and 22.5% above its 52-week low of ₹3,137.00.

Key Metrics

Current Price₹3,842.20
Market Cap₹4,091 Cr
BSE Code539997
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio60.7
Return on Equity22.74%
Return on Assets12.08%
52-Week Range₹3,137.00 – ₹4,211.00
3-Month Price Change+66.4%
Beta (1Y)1.06
Dividend Yield0.00%
HeadquartersAmritsar, Punjab
Websitewww.kwalitypharma.com

Latest Quarterly Results — Q1 FY27

Revenue₹162 Cr
Net Profit₹26 Cr
Net Margin15.8%
EPS (Basic)₹24.70
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Kwality Pharmaceuticals Ltd Quarterly Revenue and Profit Trend

Kwality Pharmaceuticals Ltd reported revenue of ₹162 Cr in Q1 FY27, up 45.6% from ₹111 Cr in Q1 FY26 and up 3.5% from ₹157 Cr in Q4 FY26. It posted a net profit of ₹26 Cr for the quarter, against a net profit of ₹12 Cr in Q1 FY26 (up 114.8%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹111 Cr (Q2 FY26) to ₹162 Cr (Q1 FY27). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹162 Cr₹26 Cr15.8%
Q4 FY26₹157 Cr₹25 Cr16.1%
Q3 FY26₹123 Cr₹16 Cr13.0%
Q2 FY26₹111 Cr₹14 Cr12.7%
Q1 FY26₹111 Cr₹12 Cr10.7%
Q4 FY25₹116 Cr₹15 Cr12.5%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 61.90% of Kwality Pharmaceuticals Ltd's shares as of Mar 2026, unchanged from Feb 2026. Delivery averaged 43.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, and various other categories such as general, beta-lactam, cephalosporins, cytotoxic (oncology), and biological. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.

Products and Services

1. Pharmaceuticals-This segment engages in manufacturing of a range of finished pharmaceutical formulations in a dosage forms, such as tablets, capsules, syrup, dry syrup, injections etc.

Business Segments

1. Pharmaceuticals-100%

Kwality Pharmaceuticals Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Kwality Pharmaceuticals Ltd₹4,091 Cr60.722.74%₹162 Cr—

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Kwality Pharmaceuticals Ltd?

Kwality Pharmaceuticals Ltd is trading at ₹3,842.20, with a market capitalisation of ₹4,091 Cr.

Which sector does Kwality Pharmaceuticals Ltd belong to?

Kwality Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Kwality Pharmaceuticals Ltd?

Kwality Pharmaceuticals Ltd has a P/E of 60.7 and a return on equity of 22.74%.

What is the stock symbol of Kwality Pharmaceuticals Ltd?

Kwality Pharmaceuticals Ltd is listed on the BSE under the scrip code 539997.

What were Kwality Pharmaceuticals Ltd's latest quarterly results?

In Q1 FY27, Kwality Pharmaceuticals Ltd reported revenue of ₹162 Cr and net profit of ₹26 Cr, with basic EPS of ₹24.7 (standalone, parsed from the company's exchange filing).

How have Kwality Pharmaceuticals Ltd's revenue and profit changed over the past year?

Kwality Pharmaceuticals Ltd reported revenue of ₹162 Cr in Q1 FY27, up 45.6% from ₹111 Cr in Q1 FY26 and up 3.5% from ₹157 Cr in Q4 FY26.

What is the promoter holding in Kwality Pharmaceuticals Ltd?

Promoters held 61.90% of Kwality Pharmaceuticals Ltd's shares as of Mar 2026, unchanged from Feb 2026.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.